Read this and answer the question

Other supportive evidence includes: a 20% difference in peak expiratory flow rate on at least three days in a week for at least two weeks, a 20% improvement of peak flow following treatment with either salbutamol, inhaled corticosteroids or prednisone, or a 20% decrease in peak flow following exposure to a trigger. Testing peak expiratory flow is more variable than spirometry, however, and thus not recommended for routine diagnosis. It may be useful for daily self-monitoring in those with moderate to severe disease and for checking the effectiveness of new medications. It may also be helpful in guiding treatment in those with acute exacerbations.

What is more variable than spirometry but not recommended?
. Testing peak expiratory flow